A Centers for Disease Control and Prevention vaccine advisory committee meeting scheduled for next week — the first since ...
The postponement comes amid concerns that HHS Secretary Robert F. Kennedy Jr., a longtime vaccine critic, could make changes ...
A meeting of U.S. vaccine advisers set for late February has been postponed, a federal official confirmed on Thursday, ...
Less than a week after newly confirmed Department of Health and Human Services (HHS) secretary Robert F. Kennedy Jr. | Less than a week after newly confirmed HHS secretary Robert F. Kennedy Jr.
The CDC's Advisory Committee on Immunization Practices was set to meet beginning February 26 and provide recommendations ...
The U.S. Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active ...
Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).
Penmenvy, which protects against five common types of disease-causing bacteria, is cleared for use in people aged 10 through ...
Thousands of U.S. health agency employees were terminated and told it was for poor performance, though they'd received strong ...
GSK's Penmenvy wins FDA approval to protect against five meningococcal serogroups. The CDC panel will vote on usage ...
The FDA approved GSK’s pentavalent meningococcal vaccine to protect children and young adults aged 10 to 25 years against ...